FREE SHIPPING ON ORDERS OVER $150

glp 1 and kidney GLP-1 agonists in the treatment of chronic disease in type 2 diabetes obesity Kidney effects of Glucagon-Like Peptide

$24.59

Quantity
- +
Description

Secondary Tool: Use #FibroScan (#VCTE) for patients with indeterminate FIB-4 or high clinical suspicion

glp 1 and kidney GLP-1 agonists in the treatment of chronic disease in type 2 diabetes obesity Kidney effects of Glucagon-Like Peptide

Indian J Med Res 139(4):568571 Rashidian A, Muhammadnejad A, Dehpour A-R, Mehr SE, Akhavan MM, Shirkoohi R et al (2016) Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4/NF-kB signaling pathway

glp 1 and kidney GLP-1 agonists in the treatment of chronic disease in type 2 diabetes obesity Kidney effects of Glucagon-Like Peptide

95% CI, 0.52-0.98)

glp 1 and kidney GLP-1 agonists in the treatment of chronic disease in type 2 diabetes obesity Kidney effects of Glucagon-Like Peptide

Brazg R., Xu L., Dalla Man C., Cobelli C., Thomas K., and Stein P

glp 1 and kidney GLP-1 agonists in the treatment of chronic disease in type 2 diabetes obesity Kidney effects of Glucagon-Like Peptide

You may also like

recommand products

Pricing

US$ 24.93

Min. order: 1 piece

4.9 (22 reviews)

Sold : Login>>